Efficacy and safety of bupleurum-containing formulas combined with chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis - Top-Institutions - MDSpire

Efficacy and safety of bupleurum-containing formulas combined with chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis

  • By

  • Shangshang Li

  • Jie Chen

  • Longzhu Ke

  • Yuanxiu Leng

  • Guanglai Cui

  • Qianyu He

  • Hong Chen

  • Ping Jiang

  • Li Luo

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #4

    Cleveland Clinic Comprehensive Breast Cancer Program
    Cleveland Clinic Comprehensive Breast Cancer Program

    Cleveland, Ohio

    Key Differentiators

    • Oncology

  • #5

    Baptist MD Anderson Cancer Center
    Baptist MD Anderson Cancer Center

    Jacksonville, Florida

    Key Differentiators

    • Oncology

Original Source(s)

Efficacy and safety of bupleurum-containing formulas combined with chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis

  • by Shangshang Li, Jie Chen, Longzhu Ke, Yuanxiu Leng, Guanglai Cui, Qianyu He, Hong Chen, Ping Jiang, Li Luo

  • July 15, 2026

Related Content

From associations to clinical practice: translating inflammatory-nutritional indices into a machine learning-driven model for breast cancer risk stratification with cross-ethnic validation

Non-bacterial cystitis following treatment with toripalimab for alpha-fetoprotein-producing gastric adenocarcinoma: a case report

Helicobacter pylori infection in gastric cancer patients in French Guiana: a hospital-based study (2018–2023)